TrialCancer research communications2024

First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study.

Duncan A Wheatley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.